Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Here’s What Happened

Curaleaf Holdings, Inc. (OTCMKTS:CURLF)’s stock price gapped down before the market opened on Thursday . The stock had previously closed at $9.70, but opened at $9.32. Curaleaf shares last traded at $9.6313, with a volume of 5,990 shares changing hands.

Wall Street Analyst Weigh In

Separately, Zacks Research downgraded Curaleaf from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, June 3rd. Two research analysts have rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy”.

Curaleaf Stock Performance

The firm has a market capitalization of $2.21 billion, a PE ratio of -24.25 and a beta of 1.51. The company has a debt-to-equity ratio of 1.05, a quick ratio of 0.74 and a current ratio of 1.56. The business’s fifty day simple moving average is $7.61 and its 200-day simple moving average is $7.53.

Curaleaf (OTCMKTS:CURLF) last issued its earnings results on Tuesday, May 5th. The company reported $0.27 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.24) by $0.51. The firm had revenue of $324.23 million during the quarter, compared to analyst estimates of $316.62 million. Curaleaf had a negative net margin of 7.76% and a negative return on equity of 8.11%. As a group, equities research analysts expect that Curaleaf Holdings, Inc. will post -0.31 EPS for the current year.

Curaleaf Company Profile

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.